U.S. cities are home to 62.7% of the American population, according to the U.S. Census Bureau. This number is expected to grow to 87.4% by 2050. Here's how healthcare can keep up.
Autoimmune diseases often impact many organ systems and are complex, requiring a number of specialists to manage them. Here’s a snapshot of an interesting new model that addresses care challenges of these diseases.
Most autoimmune diseases don’t have cures. Here are the top ways providers can manage and control them.
Slightly less than in 2018, approximately 8.5 million people signed up to obtain health insurance for 2019 through the ACA marketplace exchange. Here are five things that may or may not have affected these numbers.
Here’s a look at three innovative drugs used to treat autoimmune conditions that made the news this year.
Because of the inflammatory nature of psoriasis, biologics are good drug candidates, but could affect cost and reimbursement.
In an effort to lower prescription drug prices, CMS unveiled proposed polices for 2020 to strengthen and modernize the Medicare Part C and D programs. Here’s a closer look at what CMS’ provisions entail and how they help accomplish the Administration’s four strategies.
Medicare Advantage enrollees can expect new benefits with the start of 2019. Here's what healthcare executives should know.
Here’s how experts predict healthcare will unfold in 2019.
There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.